by Jo Inkyung
Published 20 Nov.2026 15:00(KST)
A key protein that helps regenerate damaged teeth has been identified. In animal experiments, applying the protein improved the effects of regenerative treatment: tooth roots formed about 42% larger than those in the control group.
Severance Hospital announced on November 20 that a joint research team led by Professor Dohyun Kim of Yonsei University College of Dentistry and Professor Jinman Kim of Seoul National University School of Dentistry had confirmed that fibronectin promotes interactions between immune cells and stem cells, helping generate blood vessels and regenerate dental tissue.
When severe tooth decay infects the pulp, the tissue inside a tooth containing nerves and blood vessels, the infected pulp is removed through root canal treatment. However, once the pulp is removed, dentin formation stops and the tooth root also weakens. This is especially risky for young permanent teeth whose roots have not fully developed, as they are more likely to fracture after treatment.
To find ways to improve the effectiveness of existing regenerative endodontic treatment, the research team focused on interactions between macrophages and dental pulp stem cells and confirmed that fibronectin, which connects the two cell types, plays a key role. Macrophages are immune cells that remove bacteria and damaged cells, while dental pulp stem cells are involved in regenerating tissue inside teeth. Fibronectin is a protein outside cells that helps them bind to one another.
In macrophages that came into contact with dental pulp stem cells through fibronectin, the secretion of inflammation-inducing substances decreased, while the secretion of substances that promote blood vessel formation increased. In this way, immune cells regulate the inflammatory response and create an environment conducive to tissue regeneration.
To assess the treatment's actual effects, the team conducted animal experiments on three dogs with teeth whose roots had not fully developed. The researchers compared a control group that received standard regenerative endodontic treatment with an experimental group that also received fibronectin. After eight weeks, the average cross-sectional area of the roots in the fibronectin group was 3.40 mm2, about 42% greater than the 2.39 mm2 in the control group. The proportion of roots that completed growth was also about 2.6 times higher in the fibronectin group, at 59.1% (13 of 22 teeth), than in the control group, at 22.7% (5 of 22 teeth).
When fibronectin (FN) links macrophages and dental pulp stem cells (DPSCs) in caries-damaged pulp, NF-κB signaling in macrophages is activated, increasing the secretion of angiogenic factors (CXCL chemokines and VEGF). These factors promote endothelial cell survival and blood vessel formation, helping regenerate the pulp-dentin complex.
View original imageTissue examinations also showed differences. Teeth treated with fibronectin had formed a layer of cells resembling those that produce dentin, and researchers observed the fine tubule structures characteristic of dentin as well as abundant blood vessels. By contrast, the control group showed relatively few blood vessels and mostly irregularly shaped fibrous tissue.
Professor Dohyun Kim said, "We have shown that fibronectin connects immune cells and stem cells, creating an environment conducive to blood vessel formation and tissue regeneration. Through further research, we will develop this into a new regenerative treatment that can preserve permanent teeth whose roots have not fully developed." Professor Jinman Kim said, "We confirmed that macrophages help regenerate tissue not only by regulating inflammation but also through interactions with surrounding cells. We expect this work to contribute to the development of new regenerative treatment strategies that harness the functions of immune cells."
However, this study is still at the animal testing stage. Before it can be used in humans, researchers must establish appropriate doses and methods of administration and verify its long-term safety and therapeutic effectiveness. The findings were published in the latest issue of the international journal 'Experimental & Molecular Medicine.'